Avista Q2 EPS USD 0.43
AVA•Avista reports second-quarter adjusted EPS
Aug. 3 (Reuters) - Avista Q2 adjusted EPS USD 0.29 vs. IBES estimate USD 0.24.
Related News
Pelthos Therapeutics Financial Statements Should No Longer Be Relied Upon For Quarter Ended March 31- SEC Filing
PTHS•
CorMedix beats Q2 revenue estimates on DefenCath growth, raises FY adjusted EBITDA guidance
CRMD•
American Shared Hospital Services Reports Second Quarter And First Half 2026 Financial Results
AMS•
Zenas Biopharma posts corporate presentation on autoimmune disease pipeline, led by obexelimab program
ZBIO•
Ascendis Pharma swings to Q2 profit on revenue doubling, PRV sale
ASND•